Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actos and Glucophage in Insulin Resistance
NCT00443755Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2005
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pioglitazone and metformin in type 2 diabetes mellitus (T2DM), impaired fasting glucose (IFG) and metabolic syndrome, sponsored by Mayo Clinic. Started Aug 2005; status: completed.
02
Drugs
pioglitazonemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)impaired fasting glucose (IFG)metabolic syndrome
Beyond the preview
Go deeper on NCT00443755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443755.